Literature DB >> 3110405

Absorption and disposition kinetics of cromolyn sodium and the influence of inhalation technique.

R Richards, C R Dickson, A G Renwick, R A Lewis, S T Holgate.   

Abstract

Plasma concentrations of cromolyn sodium (SCG) have been measured in 13 normal subjects on three occasions after inhalation from a Spinhaler (20 mg) delivery system under conditions of controlled inspiratory flow rate. High inspiratory flow rates were associated with high peak plasma concentrations and areas under the plasma concentration-time curve. A 10-sec breath hold at the end of inspiration did not alter significantly the plasma concentration-time curve. Instillation of SCG (1 mg) directly into a second-order bronchus of 14 patients undergoing diagnostic examination gave plasma concentration-time curves similar to those seen in normal volunteers at high inspiratory flow rates. Additional studies in normal volunteers showed that SCG was poorly absorbed from the gastrointestinal tract. The shorter terminal half-life seen after i.v. infusion compared with inhalation indicates that the drug shows absorption rate limited disposition kinetics after inhalation. These studies in large numbers of subjects support the conclusions of limited earlier investigations that SCG is absorbed slowly but almost completely from the airways, that there is little gastrointestinal absorption of SCG, that only a small proportion of the Spinhaler dose (about 10%) reaches the airways and that the amount reaching the airways is related directly to inspiratory flow rate.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3110405

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  12 in total

1.  Delivery of therapeutic aerosols to intubated babies.

Authors:  J Grigg; S Arnon; T Jones; A Clarke; M Silverman
Journal:  Arch Dis Child       Date:  1992-01       Impact factor: 3.791

2.  How much aerosol reaches the lungs of wheezy infants and toddlers?

Authors:  B Salmon; N M Wilson; M Silverman
Journal:  Arch Dis Child       Date:  1990-04       Impact factor: 3.791

3.  Inhaled histamine increases the rate of absorption of sodium cromoglycate from the lung.

Authors:  R Richards; C Fowler; S Simpson; A G Renwick; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

Review 4.  Devices for dry powder drug delivery to the lung.

Authors:  Kai Berkenfeld; Alf Lamprecht; Jason T McConville
Journal:  AAPS PharmSciTech       Date:  2015-05-12       Impact factor: 3.246

5.  Need for a comparative performance standard for dry powder inhalers.

Authors:  R Richards; M Saunders
Journal:  Thorax       Date:  1993-11       Impact factor: 9.139

6.  Deep inspiration increases the absorption of inhaled sodium cromoglycate.

Authors:  R Richards; C Fowler; S F Simpson; A G Renwick; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1989-06       Impact factor: 4.335

Review 7.  The effect of respiratory disorders on clinical pharmacokinetic variables.

Authors:  A M Taburet; C Tollier; C Richard
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

8.  Effect of methacholine induced bronchoconstriction on the pulmonary distribution and plasma pharmacokinetics of inhaled sodium cromoglycate in subjects with normal and hyperreactive airways.

Authors:  R Richards; A Haas; S Simpson; A Britten; A Renwick; S Holgate
Journal:  Thorax       Date:  1988-08       Impact factor: 9.139

Review 9.  Pharmacokinetic optimisation of asthma treatment.

Authors:  A M Taburet; B Schmit
Journal:  Clin Pharmacokinet       Date:  1994-05       Impact factor: 6.447

10.  Effects of Sodium Cromoglycate on Iranian Asthmatic Subjects Without Exposure to any Bronchoconstrictor agent.

Authors:  Tajmah Mombeini; Mohammad Reza Zahedpoure-Anaraki; Ahmad Reza Dehpour
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.